antihypertensives Flashcards
hypertension systolic and diastolic
> 130/80
six types of diuretics
carbonic anhydrase inhibitors loop thiazides potassium sparing vaptans osmotic
acetazolamide is a
carbonic anhydrase inhibitor
carbonic anhydrase inhibitors MOA
inhibition of carbonic anhydrase in PCT leads to Na and HCO3 diuresis
indications for carbonic anhydrase inhibitors
acute glaucoma
altitude sickness
metabolic alkalosis
alkalinizes urine
carbonic anhydrase inhibitors adverse effects
sulfa allergies
hypokalemia
kidney stones
metabolic acidosis due to HCO3 loss
thiazides MOA
blocks NaCl cotransporter in distal tubule leading to increased sodium and water excretion
thiazides adverse effects
increase glucose, lipids, calcium, uric acid
hypOnatremia, hypokalemia
sulfa allergies
thiazide indications
HTN
peripheral edema
nephrogenic diabetes insipidus
furosemide is a
loop diuretic
loop diuretics MOA
inhibit NKCC2 symporter on TAL of LOH leading to dilute urine
(no reabsorption of Na, K Cl)
loop diuretics adverse effects
decreased electrolytes
ototoxicity
hypotension
sulfa allergy
loop diuretics indication
HTN
edema
hypercalcemia
hypermagnesemia
can be used for hypercalcemia
loop diuretics reduce reabsorption
K sparing agents MOA
aldosterone receptor antagonist in collecting duct increases Na and water excretion while concerning K and H
aldosterone antagonist K sparing diuretics indications
weak alone, use with thiazide/loop
hypokalemia primary hyperaldosteronism HTN edema/ascites CHF
Aldosterone antagonist K sparing diuretics adverse effects
hyperkalemia
gynecomastia
ED
Metabolic acidosis
ENaC K sparing diuretics adverse effects
kidney stones
hyperkalemia
metabolic acidosis
ENaC K sparing diuretics MOA
directly inhibit epithelial Na channel in collecting duct to increase NaCl and water loss
ENaC K sparing diuretics indications
HTN
CHF
ENaC blockers
triamterene
amiloride
vasopressin antagonists
tolvaptan
conivaptan
vasopressin antagonists’ MOA
block vasopressin type 2 receptor (V2) to prevent aquaporin insertion and decrease water reabsorption
Vasopressin antagonists’ adverse effects
hepatotoxicity
hypernatremia
thirst
(it is not really used)
vasopressin antagonists indication
hyponatremia (but they correct this too quickly)
mannitol is a(n)
osmotic agent
osmotic agents MOA
mannitol is a non-metabolized sugar which increases osmotic pressure of glomerular filtrate
draws more water into tubule to decrease reabsorption and increase diuresis
mannitol indications
elevated intracranial or intra-ocular pressure
urogenital irrigation
(not as an antiHTN)
mannitol adverse effects
hypotension
hypovolemia
pulmonary edema
vesicant >5% concentration
CCBs general MOA
bind to and block L-type calcium channels in smooth muscle cells leading to vasodilation and a drop in BP
DHP rx
amlodipine
nifedipine
nicardipine
clevidipine
DHPs primarily act on
vascular smooth muscles
amlodipine: arteries
Non DHP CCBs
verapamil
diltiazem
Non DHP CCBs act on
the heart
verapamil ventricles
what happens when the calcium channel is blocked?
Calcium cannot be released and the muscle cannot contract .
Ca is usually the signal for contraction
preferred DHP in pregnancy
nicardipine
Non DHPs _____ peripheral dilation, ______ HR, and ________ contractility
increase
decrease
decrease
DHPs _____ peripheral dilation
increase
adverse effects of Non-DHPs
bradycardia
heart block
gingival hyperplasia
constipation
adverse effects of DHPs
headache
peripheral edema
flushing
reflex tachycardia
indications for DHP CCBs
HTN
angina
Raynauds
indications for Non-DHP CCBs
HTN
SVT
angina
cardiomyopathy
contraindications for DHP CCBs
hypertrophic obstructive cardiomyopathy
stenotic valve defects
hypotension ACS
contraindications for Non-DHP CCBs
ACS hypotension bradycardia conduction disorders DO NOT USE WITH beta blockers
do not use ______ with Non-DHPs because it will lead to _____
Beta blockers
severe bradycardia, AV block, decreased contractility
5 classes of antihypertensives
Diuretics RAAS inhibitors CCBs Adrenergic Agents Direct-Acting Vasodilators (Drugs Really Can Alter Diastole)
RAAS inhibitors classes
Angiotensin-converting enzyme inhibitors (ACEis)
Angiotensin receptor blockers (ARBs)
ACEi names end in ____
“pril”
ARBs names end in
“sartan”
ACEi MOA
blocks angiotensin converting enzyme in RAAS which does not allow angiotensin I to be converted to angiotensin II.
decreased angiotensin II
decreased aldosterone
vasodilation
ACEis lead to a decrease in _____ and _____, which leads to ______
angiotensin II
aldosterone
vasodilation (lower BP)
ACEi indications
HTN HFrEF previous MI CKD diabetic nephropathy
2 drug classes that are nephroprotective
ACEIs and ARBs
ARBs MOA
block angiotensin II from binding to AT1 receptor which blocks the action of angiotensin II
vasodilation and lower BP
ACEis and ARBs both _____ after load and _____ BP
decrease
lower
angiotensin II causes
vasoconstriction (that is why is is targeted to treat HTN)
aliskiren is a
direct renin inhibitor
ACEi adverse effects
cough
angioedema
hypotension
hyperkalemia
ARBs adverse effects
angioedema
hyperkalemia
decreased GFR
direct renin inhibitor MOA
selectively blocks renin from activating RAAS which stops the whole process upstream so that vasoconstriction is decreased
decreased BP
direct renin inhibitors adverse effects
diarrhea
hyperkalemia
teratogenicity
direct renin inhibitors contraindications
pregnancy
if taking ACEs and ARBs (hyperkalemia)
DM
ACEI/ARBs contraindications
pregnancy
aortic stenosis
renal artery stenosis
do not combine ____ and ACEI/ARBs
direct renin inhibitors
initial HTN treatment for a diabetic patient
ACEIs or ARBs
increase in bradykinin concentration can lead to
dry cough
bradykinin mediated angioedema
bradykinin is increased with use of what rx
ACEi
bradykinin
inflammatory marker that leads to vasodilation
chronotropic
affects HR
inotropic
affects contractility
alpha 1 blockers
doxazosin
prazosin
terazoin
a1 blockers MOA
block a1 receptor on vascular smooth muscle to cause vasodilation
a1 blockers adverse effects
orthostatic hypotension
dizziness
nausea
prazosin indication
HTN
terazosin/doxazosin indication
BPH
HTN
A2 agonists
methyldopa
clonidine
a2 agonists MOA
agonize A2 receptors to decrease vasoconstriction and lower BP
direct vasodilators
hydralazine
minoxidil
direct vasodilators MOA
direct relaxation of vascular smooth muscles to increase vasodilation and lower BP
direct vasodilators adverse effects
rebound tachycardia